Bank of Nova Scotia increased its Pfizer share stake by 42.4% in Q4, bringing holdings to $225.71m.

Bank of Nova Scotia increased its stake in Pfizer by 2,336,209 shares during the fourth quarter, bringing its total holdings to 7,840,192 shares, worth $225.71 million. This marks a 42.4% increase in the bank's holdings. Other institutional investors, including Norges Bank, Charles Schwab Investment Management Inc., and Morgan Stanley, have also recently modified their holdings of Pfizer shares.